ABC | Volume 114, Nº4, Abril 2020

Artigo Original Güneş et al. Tecido adiposo epicárdico e resistência à insulina Arq Bras Cardiol. 2020; 114(4):675-682 1. World Health Organization. (WHO). “Global and regional trends by UN Regions, 1990–2025; Overweight:1 990-2015”. Genrva;2016. [Cited in 2018 Jan 10] Available from: http://apps.who.int/gho/data/node.main. NUTUNREGIONS? 2. Lobstein T, Jackson-Leach R, MoodieML, Hall KD, Gortmaker SL, Swinburn BA,et al. Child, and adolescent obesity: part of a bigger picture. Lancet. 2015;385(9986):2510-20. 3. deOnisM,BlössnerM,BorghiE.Globalprevalenceandtrendsofoverweight and obesity among preschool children. Am J ClinNutr. 2010;92(5):1257-64. 4. OgdenCL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806-14. 5. Strauss RS, Bradley LJ, Brolin RE. Gastric bypass surgery in adolescents with morbid obesity. J Pediatr. 2001;138(4): 499-504. 6. Roberto CA, Swinburn B, Hawkes C, Huang TT, Costa SA, Ashe M, et al. Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking. Lancet. 2015;385(9985):2400-9. 7. HanJC,LawlorDA,KimmSY.Childhoodobesity.Lancet.2010;375(9727):1737-48. 8. Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL, Steinberger J, et al. American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Nutrition, Physical Activity and Metabolism, and Council on Clinical Cardiology. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the AmericanHeart Association. Circulation. 2013 8;128(15):1689-712. 9. Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab. 2005 ;90(11):6300-2. 10. Mazur A, Osta ń ski M, Telega G, Malecka-Tendera E. Is epicardial fat tissue a marker of metabolic syndrome in obese children? Atherosclerosis. 2010;211(2):596-600. 11. AbateN, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest.1995;96(1):88-98. 12. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes. 1996;45(12):1684-93. 13. ChandaliaM, AbateN, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab.1999;84(7):2329-35. 14. Sharma AM. Mediastinal fat, insulin resistance, and hypertension. Hypertension. 2004;44(2):117-8. 15. El-AssaadI,Al-KindiSG,SaarelEV,AzizPF.Lonepediatricatrialfibrillationinthe Un itedStates:analysisofover1500cases.PediatrCardiol. 2017;38(5):1004–9. 16. Gunes H, Sokmen A, Kaya H, Gungor O, Kerkutluoglu M, Guzel FB, et al. Evaluation of Atrial Electromechanical Delay to Predict Atrial Fibrillation in Hemodialysis Patients. Medicina (Kaunas). 2018; 54(4): E58. 17. Kurt M, Tanboğa IH, Karakaş MF, Büyükkaya E, Akcay AB, Sen N, et al. The relationship between atrial electromechanical delay and P-wave dispersion with the presence and severity of metabolic syndrome. Turk Kardiyol Dern Ars. 2012;40(8):663-70. 18. Zehir R, Karabay CY, Kocabay G, Kalayci A, Kaymaz O, Aykan AC, et al. Assessment of atrial conduction time in patients with polycystic ovary syndrome. J Interv Card Electrophysiol.2014;41(2):137-43. 19. Barlow SE. Expert Committee recommendations re¬garding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(suppl 4); p164-92. 20. Shashaj B, Luciano R, Contoli B, Morino GS, Spreghini MR, Rustico C, et al. Reference ranges of HOMA-IR in normal-weight and obese young Caucasians. Acta Diabetol. 2016;53(2):251-60. 21. Iacobellis G., Lonn E., Lamy A. Epicardial fat thickness and coronary artery diseasecorrelate independentlyofobesity. Int JCardiol.2011;146(3):452–4. 22. Castro AV, Kolka CM, Kim SP, Bergman RN. Obesity, insulin resistance, and comorbidities? Mechanisms of association. Arq Bras Endocrinol Metabol.2014;58(6):600-9. 23. Gobato AO, Vasques AC, Zambon MP, Barros Filho A, Hessel G. Metabolic syndrome and insulin resistance in obese adolescents. Rev Paul Pediatr. 2014;32(1):55-62. 24. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500–3. 25. SouzaMS, Leme RB, Franco RR, Romaldini CC, Tumas R, Cardoso AL, et al. Metabolic syndrome in obese and overweight adolescents. Rev Paul Pediatr. 2007;25:214–20. 26. Juárez-López C, Klünder-Klünder M, Medina-Bravo P, Madrigal-Azcárate A, Mass-Díaz E, Flores-Huerta S. Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Public Health. 2010 Jun 07;10:318 27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations inman. Diabetologia. 1985;28(7):412–9. 28. Cho ME, Craven TE, Cheung AK, Glasser SP, Rahman M, Soliman EZ, et al. SPRINT Study Research Group. The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial). J Clin Hypertens (Greenwich). 2017;19(11):1152-61. 29. Nyman K, Granér M, PentikäinenMO, Lundbom J, Hakkarainen A, Sirén R, et al. Metabolic syndrome associates with left atrial dysfunction. Nutr Metab Cardiovasc Dis. 2018;28(7):727-34. 30. De Sensi F, Costantino S, Limbruno U, Paneni F. Atrial fibrillation in the cardiometabolic patient. Minerva Med. 2019;110(2):157-67. Referências Fontes de financiamento Opresente estudo não teve fontes de financiamento externas. Vinculação acadêmica Não há vinculação deste estudo a programas de pós‑graduação. Aprovação ética e consentimento informado Este estudo foi aprovado pelo Comitê de Ética da Kahramanmaraş Sütçü İmam University sob o número de protocolo 349/2019. Todos os procedimentos envolvidos nesse estudo estão de acordo com a Declaração de Helsinki de 1975, atualizada em 2013. O consentimento informado foi obtido de todos os participantes incluídos no estudo. 681